News

Neuberger Berman Fund Announces New Monthly Distribution Plan

Neuberger Berman Fund Announces New Monthly Distribution Plan

Neuberger Berman Fund Distribution Announcement

Neuberger Berman Energy Infrastructure and Income Fund Inc. (NYSE: NML) has made a significant announcement regarding its monthly distributions. The Fund will distribute a monthly cash amount of $0.0584 per share to its common stockholders. This initiative reflects the Fund's commitment to providing reliable returns to its investors, which is a part of its broader strategy aimed at stabilizing shareholder returns.

Monthly Distributions and Record Dates

Details of the Distribution

The distribution declared today is set to be paid on October 31, and it follows a structured timeline established by the Fund. The record date for stockholders is October 15, which means that all investors on record as of that date will be eligible for this distribution. Moreover, the ex-dividend date also matches October 15, ensuring clarity for investors looking to understand their eligibility.

Understanding the Fund's Approach

This Fund takes a prudent approach towards its financial obligations, primarily aiming to deliver monthly cash distributions. These distributions are carefully calculated based on several factors, including projected net returns from investments in energy infrastructure, cash flows, and distribution from master limited partnerships (MLPs) and similar entities.

Use of Distributable Cash Flow

Neuberger Berman plans to utilize its distributable cash flow for these distributions. Distributable cash flow generally includes various income sources such as cash and paid-in-kind distributions, dividends, interest from debt instruments, and earnings from other investments. However, it is important to note that this cash flow will be adjusted for any operating expenses and taxes, which may influence the net amount available for distribution.

Tax Implications for Shareholders

It's essential for shareholders to be aware that a portion of these distributions may represent a non-taxable return of capital. A return of capital indicates a distribution that reflects a return of the stockholder’s original investment. It is crucial not to confuse this with standard dividends, as such distributions will adjust an investor's basis in the Fund's shares, potentially affecting capital gains or losses upon resale.

Distribution Notices

Federal Income Tax Considerations

Unlike most investment entities, this Fund is subject to federal income tax on any taxable income it generates. Taxes levied on its operations can reduce the funds available for distribution to stockholders, meaning that investors may receive lower disbursements compared to what they would earn by investing directly in MLPs.

About Neuberger Berman

Founded in 1939, Neuberger Berman is a well-respected, employee-owned investment management firm. With more than 2,800 employees operating across 26 countries, the firm has amassed an impressive portfolio of around $538 billion, which includes equities, fixed income, private equity, real estate, and hedge funds. The firm emphasizes active management and fundamental research, consistently earning accolades as a top workplace in the financial services sector.

Company Contact Information

For further inquiries, investors can reach out to Neuberger Berman Investment Advisers LLC at (877) 461-1899 for investor information.

Frequently Asked Questions

What is the recent distribution amount announced by Neuberger Berman?

The recent distribution announced by Neuberger Berman is $0.0584 per share of common stock.

When will the distribution payment occur?

The payment for the recent distribution will take place on October 31, 2025.

What is a return of capital in the context of distributions?

A return of capital is a distribution that returns a portion of a shareholder's initial investment, which may impact tax obligations differently compared to regular dividends.

How does the Fund generate cash for distributions?

The Fund generates cash through its investments in MLPs, dividends received from stocks, interest from various debt instruments, and other investment returns after accounting for expenses.

What tax obligations does the Fund have?

The Fund is subject to federal income tax on its taxable income, which can affect the amount available for distributions to shareholders.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading